Zora and Mayo Medical Laboratories to collaborate on Plasma Ceramide Testing

Zora and Mayo Medical Laboratories  has signed Collaborate on Plasma Ceramides Testing.  The test will be launched in summer, and is used to predict adverse…

Read more

Zora at EAS 2016 Innsbruck

Zora participates 84th EAS Congress at Innsbruck, Austria. Our CMO Reijo Laaksonen presents our latest results on cardiovascular risk prediction in statin treated patients at…

Read more

Zora at Nature Reviews Research Highlights

Zora's recent publication on CERT was reviewed in Nature Reviews Cardiology Research Highlights. Read the research highlight here.

Read more

New biomarker for identification of coronary artery disease patients at high risk for cardiovascular death

Zora Biosciences in collaboration with academic research groups from Finland, Germany, Austria,  Switzerland and Norway have shown that plasma ceramides are significant predictors of cardiovascular…

Read more

Zora has updated visual identity

We have renewed our visual identity. Zora logo is now modernized. Inspiration for the new logo comes from the six carbon ring that is commonly…

Read more

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

Laaksonen et al. European Heart Journal, Published online: 28 April 2016

Read more  

Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

Hilvo et al. Cancer Res. 2016 Feb 15;76(4):796-804

Read more  

Lipidomics: a tool for studies of atherosclerosis

Ekroos K et al. Curr Atheroscler Rep. 2010 Jul;12(4):273-81

Read more  

Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides

Kauhanen D et al. Anal Bioanal Chem. 2016 May;408(13):3475-83

Read more  

Lipidomics in drug discovery

Vihervaara T et al. Drug Discov Today 2014 Feb;19(2):164-70

Read more  

STOMPing forward: statins, muscle complaints and CK

Laaksonen R. Atherosclerosis. 2013 Oct;230(2):256-7

Read more  

Beyond LDL-C lowering: distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency

Jänis et al. Atherosclerosis 2013 Jun;228(2):380-5

Read more  

Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome

Laaksonen R. Cardiovasc Drugs Ther. 2016 Feb;30(1):19-32

Read more  

Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study

Cheng JM et al. Atherosclerosis 2015 Dec;243(2):560-6.

Read more  

Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency

Tarasov K et al. J Clin Endocrinol Metab. 2014 Jan;99(1):E45-52

Read more  

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese

Puri P et al. J Lipid Res. 2016 Mar 28

Read more  

Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples

Heiskanen LA et al. Anal Chem. 2013 Sep 17;85(18):8757-63

Read more  

RNA-Seq and Mass-Spectrometry-Based Lipidomics Reveal Extensive Changes of Glycerolipid Pathways in Brown Adipose Tissue in Response to Cold

Marcher et al. Cell Rep. 2015 Dec 1;13(9):2000-13

Read more  

Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.

Skorve J et al. Lipids Health Dis. 2015 Aug 11;14:88

Read more